27 July 2023 - Patients are struggling to get hold of the new medicines they desperately need and ask what ...
25 July 2023 - Frustrated after countless failed diet and exercise attempts, 41 year old Jessica Lenth from Hamburg has ...
30 August 2022 - In this cohort study comparing 599 medicine approvals in the US and Germany between 2004 and 2018, ...
3 April 2022 - Bluebird bio is a highly innovative biotechnology company which develops gene therapies for several rare genetic ...
26 August 2020 - The launch marks the first European market entry for Nepexto. ...
24 June 2020 - Novartis is set to launch its one-off gene therapy Zolgensma for the ultra-rare muscle-wasting disease spinal ...
8 July 2019 - New payment models, dedicated investment, and better health technology assessment are among a raft of changes ...
12 Septemner 2018 - Novartis' breakthrough cancer drug Kymriah has been approved in Europe. Now comes the debate about its ...
19 December 2016 - Vertex Pharmaceuticals today announced it has reached a pricing and reimbursement agreement for Orkambi (lumacaftor with ...